Irradiation induces cancer lung metastasis through activation of the cGAS-STING-CCL5 pathway in mesenchymal stromal cells
Open Access
- 7 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (5), 1-10
- https://doi.org/10.1038/s41419-020-2546-5
Abstract
Emerging evidence indicates that mesenchymal stromal cells (MSCs) have an important role in cancer metastasis. Although tumor microenvironment, which includes MSCs and immune cells, can be altered by ionizing radiation (IR), whether irradiation can promote metastasis through MSCs remains unclear. Using the lung colonization model of transplanted 4T1 breast cancer cells, we found an increased lung metastasis in mice exposed to ionizing radiation, even when the thorax was shielded during whole-body irradiation. This radiation-induced lung metastasis can be replicated using irradiated MSCs. cGAS-STING signaling pathway was found to be activated in MSCs, accompanied by upregulation of type I interferon-related genes, including chemokine CCL5. Disruption of cGAS-STING signaling in MSCs abolished their pro-metastatic effect. Deletion of CCL5 in MSCs also abrogated the pro-metastatic effect endowed by IR. Furthermore, we showed that the lung pro-metastatic effect of irradiated MSCs required the presence of macrophages. Our results indicate that radiation-induced alterations in distant mesenchymal stromal cells facilitate cancer metastasis.This publication has 27 references indexed in Scilit:
- Characteristics and Significance of the Pre-metastatic NicheCancer Cell, 2016
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic TumorsImmunity, 2014
- Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012Radiotherapy and Oncology, 2014
- Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapyCancer Biology & Therapy, 2014
- Mobilization of Viable Tumor Cells Into the Circulation During Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2014
- cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STINGNature, 2013
- Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNAScience, 2013
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cellsJournal of Cellular Physiology, 2007
- Radiation and the microenvironment – tumorigenesis and therapyNature Reviews Cancer, 2005